Our mission
“Redefining Treatment Through Synergy”
By combining a multifunctional, integrated stress response‑based therapy with a second therapy acting on complementary pathways, Enemsa Pharma aims at unlocking real efficacy in rare neurodegenerative and cardiopulmonary diseases.
Latest news
Event
Enemsa Pharma is pleased to announce its participation in the BIO International Convention, taking place from June 22 to 25, 2026, in San Diego, USA. We look forward to meeting our partners and industry peers to explore new business collaboration opportunities.
See event
Enemsa Pharma is pleased to announce its participation in the BIO-Europe Conference, taking place from November 9 to 11, 2026 in Cologne, Germany. We look forward to meeting our partners and industry colleagues to discuss potential collaborations and new business opportunities.
See event 
Enemsa Pharma is pleased to announce its attendance at the 31st world congress on “Parkinson’s Disease and related disorders” to be held in Milano, Italy from November 11 to 14, 2026.
See event